In the PEACE trial conducted by Brian A Bergmark et al. [19], it was discovered that a low concentration of Klotho was strongly associated with an increased risk of CV death or hospitalization for heart failure in individuals with stable ischemic heart disease over a six-year follow-up period (adjusted hazard ratio 2.62) [19]. The gene discussed is KL; the disease is heart failure.